Loading...

Cytek Biosciences, Inc.

CTKB•NASDAQ
Healthcare
Medical - Devices
$4.40
$0.14(3.29%)
U.S. Market opens in 30h 28m

Cytek Biosciences, Inc. (CTKB) Stock Overview

Explore Cytek Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap565.6M
P/E Ratio-8.58
EPS (TTM)$-0.52
ROE-0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$3.85
3 Months$2.68
1 Year Target$2.36

CTKB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cytek Biosciences, Inc. (CTKB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.58 and a market capitalization of 565.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.29%
5-Day Change
-6.58%
1-Month Change
-4.97%
3-Month Change
-16.51%
6-Month Change
3.29%
Year-to-Date (YTD) Change
-12.87%
1-Year Change
15.18%
3-Year Change
-56.65%
5-Year Change
-76.55%
All-Time (Max) Change
-76.55%

Contact Information

https://cytekbio.com
877 922 9835
47215 Lakeview Boulevard, Fremont, CA, 94538

Company Facts

663 Employees
IPO DateJul 23, 2021
CountryUS
Actively Trading

Frequently Asked Questions